US Patent Issued to OSCOTEC on July 8 for "Pyridopyrimidinone derivatives for use as AXL inhibitors" (South Korean Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,272, issued on July 8, was assigned to OSCOTEC INC. (Seongnam-si, South Korea).

"Pyridopyrimidinone derivatives for use as AXL inhibitors" was invented by Jung-Ho Kim (Seongnam-si, South Korea), Jang-Sik Choi (Cheonan-si, South Korea), Hee Kyu Lee (Suwon-si, South Korea), Dong-Sik Jung (Cheonan-si, South Korea), Sung-Ho Park (Siheung-si, South Korea) and Yung-Geun Choi (Suwon-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Pyridopyrimidinone derivatives and pharmaceutical compositions containing the same for use as an Axl inhibitor for the treatment of a disease or condition mediated by Axl such as cancer and metastasis, are disclosed....